n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with prostaglandin f1 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bing, RJ; Ingram, M; Miyataka, M; Rich, KA; Yamamoto, T | 1 |
Aras-López, R; Arroyo-Villa, I; Balfagón, G; Blanco-Rivero, J; Ferrer, M; Márquez-Rodas, I; Xavier, FE | 1 |
2 other study(ies) available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and prostaglandin f1
Article | Year |
---|---|
Nitric oxide, anti-inflammatory drugs on renal prostaglandins and cyclooxygenase-2.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Isoenzymes; Kidney; Male; Nitrates; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Prostaglandins F; Pyrazoles; Rabbits; Salicylates; Sulfonamides; Thromboxane B2 | 2002 |
Long-term fenofibrate treatment impairs endothelium-dependent dilation to acetylcholine by altering the cyclooxygenase pathway.
Topics: Acetylcholine; Animals; Blotting, Western; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Endothelium, Vascular; Fenofibrate; In Vitro Techniques; Indomethacin; Male; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Prostaglandins F; Rats; Rats, Wistar; Sulfonamides; Time Factors; Vasodilation; Vasodilator Agents | 2007 |